Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Drug Class Review: Triptans: Final Report Update 4 [Internet].

Helfand M, Peterson K.

Portland (OR): Oregon Health & Science University; 2009 Jun.

2.

Comparative aspects of triptans in treating migraine.

Adelman JU, Lewit EJ.

Clin Cornerstone. 2001;4(3):53-64. Review.

PMID:
12739316
3.

Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Tfelt-Hansen P, De Vries P, Saxena PR.

Drugs. 2000 Dec;60(6):1259-87. Review.

PMID:
11152011
4.

Rational migraine management: optimising treatment with the triptans.

Millson DS.

Funct Neurol. 2000;15 Suppl 3:182-91. Review.

PMID:
11200789
5.

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Ferrari MD, Goadsby PJ, Roon KI, Lipton RB.

Cephalalgia. 2002 Oct;22(8):633-58. Erratum in: Cephalalgia. 2003 Feb;23(1):71..

PMID:
12383060
6.

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Ferrari MD, Roon KI, Lipton RB, Goadsby PJ.

Lancet. 2001 Nov 17;358(9294):1668-75.

PMID:
11728541
7.

Triptans for the management of migraine.

Johnston MM, Rapoport AM.

Drugs. 2010 Aug 20;70(12):1505-18. doi: 10.2165/11537990-000000000-00000. Review.

PMID:
20687618
8.

Newer formulations of the triptans: advances in migraine management.

Gladstone JP, Gawel M.

Drugs. 2003;63(21):2285-305. Review.

PMID:
14524731
9.

[Clinical use of triptans in the management of migraine].

Lantéri-Minet M.

CNS Drugs. 2006;20 Spec no.1:12-23. Review. French.

PMID:
16841523
10.

Patterns of use of triptans and reasons for switching them in a tertiary care migraine population.

Sheftell FD, Feleppa M, Tepper SJ, Volcy M, Rapoport AM, Bigal ME.

Headache. 2004 Jul-Aug;44(7):661-8.

PMID:
15209687
11.

Triptans in pregnancy.

Soldin OP, Dahlin J, O'Mara DM.

Ther Drug Monit. 2008 Feb;30(1):5-9. doi: 10.1097/FTD.0b013e318162c89b. Review.

12.

Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.

McCormack PL, Foster RH.

Pharmacoeconomics. 2005;23(12):1283-98. Review.

PMID:
16336021
13.

Comparative efficacy of triptans for the abortive treatment of migraine: a multiple treatment comparison meta-analysis.

Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, Goadsby PJ.

Cephalalgia. 2014 Apr;34(4):258-67. doi: 10.1177/0333102413508661. Epub 2013 Oct 9.

PMID:
24108308
14.
15.

The use of triptans for pediatric migraines.

Eiland LS, Hunt MO.

Paediatr Drugs. 2010 Dec 1;12(6):379-89. doi: 10.2165/11532860-000000000-00000. Review.

PMID:
21028917
16.

Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.

Johnson DE, Rollema H, Schmidt AW, McHarg AD.

Eur J Pharmacol. 2001 Aug 17;425(3):203-10.

PMID:
11513839
17.

Drug Class Review on Triptans: Final Report Update 3 [Internet].

Helfand M, Peterson K.

Portland (OR): Oregon Health & Science University; 2005 Nov.

18.

Spotlight on rizatriptan in migraine.

Wellington K, Jarvis B.

CNS Drugs. 2002;16(10):715-20. Review.

PMID:
12269863
19.

Rizatriptan: an update of its use in the management of migraine.

Wellington K, Plosker GL.

Drugs. 2002;62(10):1539-74. Review.

PMID:
12093318
20.

Formulation Approaches of Triptans for Management of Migraine.

Kassem AA.

Curr Drug Deliv. 2016;13(6):882-98. Review.

PMID:
27109335
Items per page

Supplemental Content

Write to the Help Desk